Asthma and allergies drug Singulair as generic version approved

FDA approves first generic versions of Singulair to treat asthma, allergies – The U.S. Food and Drug Administration approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies.

Sinus infection rhinosinusitis may lead to toxic shock syndrome

Rhinosinusitis should be considered the primary cause of TSS when another site of infection has not been identified. – Rhinosinusitis (infection and inflammation in the sinus passages surrounding the nose) appears to be a primary factor in about one-fifth of toxic shock syndrome cases in children.

Do NOT follow this link or you will be banned from the site!